High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
In thalassemia, deficient globin-chain production during erythropoiesis results in anemia. Thalassemia may be further complicated by iron overload (frequently exacerbated by blood transfusion), which induces numerous endocrine diseases, hepatic cirrhosis, cardiac failure and even death. Accumulation of iron in the absence of blood transfusions may result from inappropriate suppression of the iron-regulating peptide hepcidin by an erythropoietic mechanism. To test this hypothesis, we examined erythroblast transcriptome profiles from 15 healthy, nonthalassemic donors. Growth differentiation factor 15 (GDF15), a member of the transforming growth factor-beta superfamily, showed increased expression and secretion during erythroblast maturation. Healthy volunteers had mean GDF15 serum concentrations of 450 +/- 50 pg/ml. In comparison, individuals with beta-thalassemia syndromes had elevated GDF15 serum levels (mean 66,000 +/- 9,600 pg/ml; range 4,800-248,000 pg/ml; P < 0.05) that were positively correlated with the levels of soluble transferrin receptor, erythropoietin and ferritin. Serum from thalassemia patients suppressed hepcidin mRNA expression in primary human hepatocytes, and depletion of GDF15 reversed hepcidin suppression. These results suggest that GDF15 overexpression arising from an expanded erythroid compartment contributes to iron overload in thalassemia syndromes by inhibiting hepcidin expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Growth-differentiation factor (GDF)-15, whose levels are increased in thalassemia and AI with or without ID, also inhibits HAMP expression [60, 64].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [60]
In the citing paper
“However, in being the primary iron source for erythropoiesis, TF also indirectly regulates HAMP expression via erythroid progenitor-derived mediators, suggesting that the pathways of HAMP regulation are interconnected [59–61].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [60]
In the citing paper
“Growth differentiation factor 15 (GDF-15) and twisted gastrulation homolog 1 (TWSG1) have been identified as candidate erythrokines, although not erythroblast-specific, that have the potential to suppress hepcidin under conditions of increased erythropoietic activity.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
In the citing paper
“GDF15 is an iron- and O2-regulated (HIF-independent) member of the TGF-β superfamily, which is secreted from maturing erythroblasts and has been shown to suppress hepcidin transcription in primary human hepatocytes and hepatoma cells”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
In the citing paper
“This is in contrast to previous reports where higher doses of GDF15 were needed to achieve hepcidin suppression in human HuH-7 hepatoma cells and in primary hepatocytes, while low dose GDF15 treatment increased hepcidin.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Weatherall, D. J., & Clegg, J. B. (2001) · Wiley eBooks · doi:10.1002/9780470696705 · Cited by 1,069
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026 · cited 1×
“Recently, transforming growth factor-β (TGFB) superfamily members have been identified as regulators of hepcidin expressio”
BackgroundRund, D., & Rachmilewitz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050436 · Cited by 939
(1973) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1973.tb111034.x · Cited by 811
Regulation of Iron Metabolism by Hepcidin
Nemeth, E., & Ganz, T. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111303 · Cited by 756
Self-citationA role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression
Wang, R.-H., Li, C., Xu, X., Zheng, Y., Xiao, C., Zerfas, P., Cooperman, S., Eckhaus, M., Rouault, T., Mishra, L., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.10.010 · Cited by 614 · cited 1×
“Recently, transforming growth factor-β (TGFB) superfamily members have been identified as regulators of hepcidin expressio”
BackgroundSelf-citationXu, J., Kimball, T. R., Lorenz, J. N., Brown, D. A., Bauskin, A. R., Klevitsky, R., Hewett, T. E., Breit, S. N., & Molkentin, J. D. (2006) · Circulation Research · doi:10.1161/01.res.0000202804.84885.d0 · Cited by 506 · cited 1×
“Studies in cardiomyocytes suggest that GDF15 activates Smad2/3 signalin”
BackgroundLarge-Scale Delineation of Secreted Protein Biomarkers Overexpressed in Cancer Tissue and Serum
Welsh, J. B., Sapinoso, L. M., Kern, S. G., Brown, D. A., Liu, T., Bauskin, A. R., Ward, R. L., Hawkins, N. J., Quinn, D. I., Russell, P. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530278100 · Cited by 503 · cited 1×
“Elevated serum GDF15 concentrations have been reported in a variety of cancer”
BackgroundThe transforming growth factor-β superfamily of receptors
de Caestecker, M. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.10.004 · Cited by 464
Cited by
Items 101–200 of 865
Nairz, M., Theurl, I., Wolf, D., & Weiss, G. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-016-0505-7 · Cited by 152
“or without ID, also inhibits HAMP expression [60, 64].”
BackgroundForejtnikovà, H., Vieillevoye, M., Zermati, Y., Lambert, M., Pellegrino, R. M., Guihard, S., Gaudry, M., Camaschella, C., Lacombe, C., Roetto, A., et al. (2010) · Blood · doi:10.1182/blood-2010-04-281360 · Cited by 152
Suragani, R. N. V. S., Cawley, S. M., Li, R., Wallner, S., Alexander, M. J., Mulivor, A. W., Gardenghi, S., Rivella, S., Grinberg, A. V., Pearsall, R. S., et al. (2014) · Blood · doi:10.1182/blood-2013-06-511238 · Cited by 148
“Finally, treatment of Hbb mice with RAP-536 did not significantly alter splenic expression of Gdf15 or twisted gastrulation (Twsg1) (supplemental Figure 5C-D), identified previously as potential erythroid regulators.(29,30) Together, these results demonstrate that RAP-536 treatment improves iron homeostasis in Hbb mic…”
BackgroundIron in the Tumor Microenvironment-Connecting the Dots
Pfeifhofer-Obermair, C., Tymoszuk, P., Petzer, V., Weiss, G., & Nairz, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00549 · Cited by 151
Piperno, A., Galimberti, S., Mariani, R., Pelucchi, S., Ravasi, G., Lombardi, C., Bilo, G., Revera, M., Giuliano, A., Faini, A., et al. (2011) · Blood · doi:10.1182/blood-2010-08-299859 · Cited by 151
Self-citationIneffective Erythropoiesis in β‐Thalassemia
Ribeil, J.-A., Arlet, J.-B., Dussiot, M., Cruz Moura, I., Courtois, G., & Hermine, O. (2013) · The Scientific World Journal · doi:10.1155/2013/394295 · Cited by 138
Molecular mechanisms of normal iron homeostasis
Zhang, A.-S., & Enns, C. A. (2009) · Hematology · doi:10.1182/asheducation-2009.1.207 · Cited by 143
Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB
Sonnweber, T., Nachbaur, D., Schroll, A., Nairz, M., Seifert, M., Demetz, E., Haschka, D., Mitterstiller, A.-M., Kleinsasser, A., Burtscher, M., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305317 · Cited by 145
Hepcidin: A Promising Therapeutic Target for Iron Disorders A Systematic Review
Liu, J. L., Sun, B., Yin, H.-J., & Liu, S. (2016) · Medicine · doi:10.1097/md.0000000000003150 · Cited by 156
“Recent evidences suggest that 3 proteins (namely ERFE, TWSG1, and GDF15) are dictated to Hamp suppression in b-thalassemia mice.(47,50,52)”
BackgroundMolecular liaisons between erythropoiesis and iron metabolism
Kautz, L., & Nemeth, E. (2014) · Blood · doi:10.1182/blood-2014-05-516252 · Cited by 135
“In vitro, high concentrations of GDF15 or TWSG1 suppressed hepcidin expression in primary hepatocytes or hepatocyte cell lines.(14,15) However, the role of GDF15 and TWSG1 in hepcidin suppression in vivo is less clear.”
BackgroundInfluentialViatte, L., & Vaulont, S. (2009) · Biochimie · doi:10.1016/j.biochi.2009.06.012 · Cited by 166
Growth differentiation factor 15 in erythroid health and disease
Tanno, T., Noel, P., & Miller, J. L. (2010) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328337b52f · Cited by 139
Self-citationIRP1 regulates erythropoiesis and systemic iron homeostasis by controlling HIF2α mRNA translation
Wilkinson, N., & Pantopoulos, K. (2013) · Blood · doi:10.1182/blood-2013-03-492454 · Cited by 133
Hepcidin and the BMP-SMAD pathway: An unexpected liaison
Silvestri, L., Nai, A., Dulja, A., & Pagani, A. (2019) · Vitamins and Hormones · doi:10.1016/bs.vh.2019.01.004 · Cited by 124
Genetics, genetic testing, and management of hemochromatosis: 15 years since hepcidin
Pietrangelo, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.045 · Cited by 136
Tamary, H., Shalev, H., Perez-Avraham, G., Zoldan, M., Levi, I., Swinkels, D. W., Tanno, T., & Miller, J. L. (2008) · Blood · doi:10.1182/blood-2008-06-165738 · Cited by 135
“Even though the GDF15 levels in CDA I patients were elevated compared to the healthy volunteers, they did not reach the high levels detected among patients with β-thalassemia (mean 66,000 ± 9,600 pg/ml).(2) The levels of GDF15 were the”
BackgroundResultSelf-citationHepcidin Levels and Their Determinants in Different Types of Myelodysplastic Syndromes
Santini, V., Girelli, D., Sanna, A., Martinelli, N., Duca, L., Campostrini, N., Cortelezzi, A., Corbella, M., Bosi, A., Reda, G., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023109 · Cited by 135
“As regards to the hepcidin suppression from the erythropietic drive, our results argue against a role of GDF-15 as the putative mediator of this biological effect in MDS, at variance with what observed in thalassemic syndromes [10].”
BackgroundResultInfluentialThe Regulation of Hepcidin and Its Effects on Systemic and Cellular Iron Metabolism
Fleming, M. D. (2008) · Hematology · doi:10.1182/asheducation-2008.1.151 · Cited by 133
-Thalassemia Intermedia: A Clinical Perspective
Musallam, K. M., Taher, A. T., & Rachmilewitz, E. A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a013482 · Cited by 133
“Three proposed regulators of hepcidin production are growth differentiation factor 15, secreted by erythroid precursors, twisted gastrulation factor 1, and hypoxia-inducible transcription factors (Tanno et al. 2007; Taher et al. 2009a).”
BackgroundIron overload in non-transfusion-dependent thalassemia: a clinical perspective
Musallam, K. M., Cappellini, M. D., Wood, J. C., & Taher, A. T. (2012) · Blood Reviews · doi:10.1016/s0268-960x(12)70006-1 · Cited by 139
Current approach to hemochromatosis
Brissot, P., Troadec, M., Bardou‐Jacquet, E., Lan, C. L., Jouanolle, A., Deugnier, Y., & Loréal, O. (2008) · Blood Reviews · doi:10.1016/j.blre.2008.03.001 · Cited by 143
“Indeed, ineffective erythropoiesis leads to growth differentiation factor 15 (GDF15) overexpression by the erythroblasts, which inhibits hepcidin expression.(112) This could explain why (hepatocytic) iron overload can develop in thalassaemia in the absence of transfusions, and why hepcidin expression is relatively low…”
BackgroundThe role of ineffective erythropoiesis in non-transfusion-dependent thalassemia
Rivella, S. (2012) · Blood Reviews · doi:10.1016/s0268-960x(12)70005-x · Cited by 126
Adaptation of iron requirement to hypoxic conditions at high altitude
Gassmann, M., & Muckenthaler, M. U. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00248.2015 · Cited by 122
“, growth differentiation factor 15 (GDF15)] when studying diseases of ineffective erythropoiesis, such as thalassemia (83).”
BackgroundSystemic iron homeostasis and erythropoiesis
Papanikolaou, G. V., & Pantopoulos, K. (2017) · IUBMB Life · doi:10.1002/iub.1629 · Cited by 146
“Growth differentiation factor 15 (GDF15) was identified as an erythroid regulator that contributes to hepcidin suppression in patients with b-thalassemia (106) or congenital dyserythropoietic anemias (107,108).”
BackgroundGangat, N., & Wolanskyj, A. P. (2013) · Seminars in Hematology · doi:10.1053/j.seminhematol.2013.06.006 · Cited by 134
“It is possible that in thalassemia overexpression of growth differentiation factor 15 (GDF15), a member of the transforming growth factor-beta superfamily occurring as a consequence of erythroid expansion, may inhibit hepcidin expression.(35) The regulation of hepcidin by hypoxia is modulated via the hypoxia inducible…”
BackgroundRivella, S. (2015) · Haematologica · doi:10.3324/haematol.2014.114827 · Cited by 123
Manipulation of the hepcidin pathway for therapeutic purposes
Fung, E., & Nemeth, E. (2013) · Haematologica · doi:10.3324/haematol.2013.084624 · Cited by 123
Hepcidin antagonists for potential treatments of disorders with hepcidin excess
Poli, M., Asperti, M., Ruzzenenti, P., Regoni, M., & Arosio, P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00086 · Cited by 124
“It was shown to downregulate hepcidin mRNA expression in primary human hepatocytes (Tanno et al., 2007).”
BackgroundSMAD7 controls iron metabolism as a potent inhibitor of hepcidin expression
Mleczko-Sanecka, K., Casanovas, G., Ragab, A., Breitkopf, K., Müller, A., Boutros, M., Dooley, S., Hentze, M. W., & Muckenthaler, M. U. (2010) · Blood · doi:10.1182/blood-2009-09-238105 · Cited by 120
Congenital dyserythropoietic anemias
Iolascon, A., Andolfo, I., & Russo, R. (2020) · Blood · doi:10.1182/blood.2019000948 · Cited by 122
Dysregulated iron metabolism in polycythemia vera: etiology and consequences
Ginzburg, Y. Z., Feola, M., Zimran, E., Várkonyi, J., Ganz, T., & Hoffman, R. (2018) · Leukemia · doi:10.1038/s41375-018-0207-9 · Cited by 149
Self-citationIron Homeostasis: Fitting the Puzzle Pieces Together
Ganz, T. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.03.008 · Cited by 131
“GDF15, a member of the BMP/TGF-b superfamily, may be one of pathological suppressors of hepcidin in the setting of b-thalassemia (Tanno et al., 2007), but it is not clear whether this molecule participates in physiological regulation of hepcidin by erythropoietic activity.”
BackgroundSelf-citationThe Pathophysiology of Transfusional Iron Overload
Porter, J. B., & Garbowski, M. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2014.04.003 · Cited by 120
Bottomley, S. S., & Fleming, M. D. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2014.04.008 · Cited by 136
Taher, A. T., Saliba, A. N., & Harb, A. (2015) · Journal of Blood Medicine · doi:10.2147/jbm.s72463 · Cited by 133
“8,9 Nevertheless, more recent studies argue against the role of GDF15 in hepcidin suppression.”
BackgroundErythropoietin and erythropoiesis
Fried, W. I. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.05.010 · Cited by 119
“Therefore, it is also a potential mediator of the erythropoietic regulator [68].”
BackgroundHepcidin modulation in human diseases: From research to clinic
Piperno, A., Mariani, R., Trombini, P., & Girelli, D. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.538 · Cited by 116
Regulation of hepcidin: Insights from biochemical analyses on human serum samples
Kemna, E., Kartikasari, A. E. R., van Tits, L. J. H., Pickkers, P., Tjalsma, H., & Swinkels, D. W. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.10.002 · Cited by 117
“The contradiction between these results and recently published absence of effects of sTfR on iron absorption and hepcidin expression in mice [23] and the presence of other potential candidates [24] show that more research is needed in the quest for the communicator between the iron consuming bone marrow and hepcidin p…”
ResultThe gut in iron homeostasis: role of HIF-2 under normal and pathological conditions
Mastrogiannaki, M., Matak, P., & Peyssonnaux, C. (2013) · Blood · doi:10.1182/blood-2012-11-427765 · Cited by 116
“Possible regulators of hepcidin expression that have been proposed include changes in transferrin saturation, increased release of soluble molecules like growth differentiation factor 15 and twisted gastrulation homolog 1 from erythroblasts, and a direct effect of EPO on hepatocytes.(91) Whether growth differentiation…”
BackgroundHepcidin in human iron disorders: Therapeutic implications
Pietrangelo, A. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.004 · Cited by 116
“1 vol. 54 j 173–181 175 Review GDF15: growth differentiation factor 15; TWSG1: twisted gastrulation protein homolog 1.”
InfluentialHemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis
Core, A. B., Canali, S., & Babitt, J. L. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00104 · Cited by 106
“Two proposed erythroid hepcidin regulators are the TGF-β /BMP superfamily modulators growth and differentiation factor 15 (GDF15) and twisted gastrulation 1 (TWSG1), at least in the context of ineffective erythropoiesis in iron loading anemias (Tanno et al., 2007, 2009) ( Figure 1 ).”
BackgroundCercamondi, C. I., Egli, I. M., Ahouandjinou, E., Dossa, R. A. M., Zeder, C., Salami, L., Tjalsma, H., Wiegerinck, E. T. G., Tanno, T., Hurrell, R. F., et al. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.30051 · Cited by 123
“Growth differentiation factor 15 (GDF-15) produced by the marrow erythroid compartment inhibits hepcidin expression and can increase iron absorption (18); however, the interaction between GDF-15 and hepcidin in malaria is unclear (19).”
BackgroundSelf-citationYoung, B., & Zaritsky, J. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02190309 · Cited by 114
“as the bone marrow signal causing hepcidin suppression (19).”
BackgroundBeta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation
Motta, I., Bou‐Fakhredin, R., Taher, A. T., & Cappellini, M. D. (2020) · Drugs · doi:10.1007/s40265-020-01341-9 · Cited by 125
Casanovas, G., Spasic, M. V., Casu, C., Rivella, S., Strelau, J., Unsicker, K., & Muckenthaler, M. U. (2013) · Haematologica · doi:10.3324/haematol.2012.069807 · Cited by 107
“It is produced in erythroid precursor cells, and high concentrations of GDF15 down-regulate hepcidin mRNA expression in primary human hepatocytes.(4) Furthermore, GDF15 concentrations are strongly increased in disorders hallmarked by increased ineffective erythropoiesis, such as β-thalassemia, congenital dyserythropoi…”
BackgroundIron Homeostasis During Pregnancy: Maternal, Placental, and Fetal Regulatory Mechanisms
Sangkhae, V., Fisher, A. L., Ganz, T., & Nemeth, E. (2023) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-061021-030404 · Cited by 125
“In humans, maternal serum concentrations of GDF15 increase with pregnancy progression, with an approximate 10-fold increase in the first trimester compared with nonpregnant controls (36).”
BackgroundInfluentialSelf-citationHepcidin regulates ferroportin expression and intracellular iron homeostasis of erythroblasts
Zhang, D.-L., Senecal, T., Ghosh, M. C., Ollivierre-Wilson, H., Tu, T., & Rouault, T. A. (2011) · Blood · doi:10.1182/blood-2011-01-330241 · Cited by 113
“18 which erythropoiesis regulates hepcidin expression is not known yet, but in beta-thalassemia it might be through GDF15 and TWSG1, two molecules of the TGF-β superfamily, which are remarkably upregulated in erythroblasts of beta-thalassemia patients.(27,28) In any case, the mechanism by which erythropoiesis regulate…”
BackgroundErythroferrone: An Erythroid Regulator of Hepcidin and Iron Metabolism
Coffey, R., & Ganz, T. (2018) · HemaSphere · doi:10.1097/hs9.0000000000000035 · Cited by 125
Self-citationde Mast, Q., Syafruddin, D., Keijmel, S., Riekerink, T. O., Deky, O., Asih, P. B., Swinkels, D. W., & van der Ven, A. J. (2010) · Haematologica · doi:10.3324/haematol.2009.019331 · Cited by 112
“IL-1ra, median (pg/mL; IQR)(2) 29 (14-61) 14 (9-45) ND”
Objectives of iron chelation therapy in myelodysplastic syndromes: more than meets the eye?
Pullarkat, V. (2009) · Blood · doi:10.1182/blood-2009-07-234062 · Cited by 108
Ineffective erythropoiesis and its treatment
Cazzola, M. (2021) · Blood · doi:10.1182/blood.2021011045 · Cited by 125
The iron-regulatory hormone hepcidin: A possible therapeutic target?
Rochette, L., Gudjoncik, A., Guénancia, C., Zeller, M., Cottin, Y., & Vergely, C. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.09.004 · Cited by 117
Clinical Relevance of Anemia and Transfusion Iron Overload in Myelodysplastic Syndromes
Cazzola, M., Porta, M. G. D., & Malcovati, L. (2008) · Hematology · doi:10.1182/asheducation-2008.1.166 · Cited by 114
Growth differentiation factor 15: A novel biomarker with high clinical potential
Desmedt, S., Desmedt, V., Vos, L. D., Delanghe, J., Speeckaert, R., & Speeckaert, M. M. (2019) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2019.1615034 · Cited by 114
“GDF-15 has been identified as an important regulator of iron homeostasis and erythropoiesis [160] (for a review, see 161].”
BackgroundGarrick, M. D., & Garrick, L. M. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.03.018 · Cited by 111
“High levels of GDF 15 in thalassemia [151] and congenital dyserythropoietic anemia type I [152] suppress”
BackgroundWeiss, G., Theurl, I., Eder, S., Koppelstaetter, C., Kurz, K., Sonnweber, T., Kobold, U., & Mayer, G. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02182.x · Cited by 107
Intestinal HIF2α promotes tissue-iron accumulation in disorders of iron overload with anemia
Anderson, E. R., Taylor, M., Xue, X., Ramakrishnan, S. K., Martin, A., Xie, L., Bredell, B. X., Gardenghi, S., Rivella, S., & Shah, Y. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314197110 · Cited by 99
“E4922–E4930 | PNAS | Published online November 26, 2013 www.pnas.org/cgi/doi/10.1073/pnas.1314197110 growth differentiation factor-15 (GDF15) and twisted gastrulation (TWSG1) (19, 20).”
BackgroundInfluentialThe mutual control of iron and erythropoiesis
Camaschella, C., Pagani, A., Nai, A., & Silvestri, L. (2016) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12505 · Cited by 97
“In addition, it was found in extremely high concentrations in the sera of beta-thalassemia patients [26], although this”
BackgroundIron metabolism: current facts and future decisions
Tandara, L., & Salamunic, I. (2012) · Biochemia Medica · doi:10.11613/bm.2012.034 · Cited by 93
Chapin, J. C., & Giardina, P. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00040-8 · Cited by 108
Iron overload in MDS—pathophysiology, diagnosis, and complications
Gattermann, N., & Rachmilewitz, E. A. (2010) · Annals of Hematology · doi:10.1007/s00277-010-1091-1 · Cited by 108
“The molecular nature of that signal remained elusive for decades, but there is now evidence that ineffective erythropoiesis is associated with increased secretion of growth differentiation factor 15 and/or TWSG1 [3, 4] by maturing erythroblasts, leading to suppressed hepcidin production in the liver [5].”
BackgroundXu, Y., Alfaro-Magallanes, V. M., & Babitt, J. L. (2020) · British Journal of Haematology · doi:10.1111/bjh.17252 · Cited by 103
Hepcidin and Anemia of the Critically Ill Patient: Bench to Bedside
Lasocki, S., Longrois, D., Montravers, P., Beaumont, C., & Riou, B. (2011) · Anesthesiology · doi:10.1097/aln.0b013e3182065c57 · Cited by 99
“Tanno et al.16 found very high concentrations of growth differentiation factor 15, a member of the transforming growth factor family produced by late erythroblasts, in patients with -thalassemia syndromes and showed that this factor was able to repress hepcidin synthesis in hepatocytes.”
BackgroundGardenghi, S., Grady, R. W., & Rivella, S. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.08.003 · Cited by 95
Iron and the liver: Update 2008
Deugnier, Y., Brissot, P., & Loréal, O. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.014 · Cited by 95
“Diferric transferrin has emerged as the potential signaling molecule related to iron stores [23] whilst hypoxia-inducible factor (HIF), transcriptional factor and the plasmatic growth differentiation factor 15 (GDF15), a member of the TGFb superfamily, have been proposed as signaling hypoxia and erythroid activity, re…”
BackgroundNai, A., Rubio, A., Campanella, A., Gourbeyre, O., Artuso, I., Bordini, J., Gineste, A., Latour, C., Besson-Fournier, C., Lin, H. Y., et al. (2016) · Blood · doi:10.1182/blood-2015-11-681494 · Cited by 97
Hereditary hemochromatosis in the post- HFE era
Olynyk, J. K., Trinder, D., Ramm, G. A., Britton, R. S., & Bacon, B. R. (2008) · Hepatology · doi:10.1002/hep.22507 · Cited by 111
Ramirez, J., Schaad, O., Durual, S., Cossali, D., Docquier, M., Beris, P., Descombes, P., & Matthes, T. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07441.x · Cited by 96
“…erythroblasts were able to produce GDF15 and that GDF15 serum levels were highly increased in ª 2008 The Authors 258 Journal Compilation ª 2008 Blackwell Publishing Ltd, British Journal of Haematology, 144, 251–262 b-thalassaemia patients with an expanded erythroid compartment (Tanno et al, 2007).”
BackgroundBajbouj, K., Shafarin, J., & Hamad, M. A. (2018) · Technology in Cancer Research & Treatment · doi:10.1177/1533033818764470 · Cited by 99
Iron Loading and Overloading due to Ineffective Erythropoiesis
Tanno, T., & Miller, J. L. (2010) · Advances in Hematology · doi:10.1155/2010/358283 · Cited by 92
Self-citationRegulation of growth differentiation factor 15 expression by intracellular iron
Lakhal, S., Talbot, N. P., Crosby, A., Stoepker, C., Townsend, A. R. M., Robbins, P. A., Pugh, C. W., Ratcliffe, P. J., & Mole, D. R. (2009) · Blood · doi:10.1182/blood-2008-07-170431 · Cited by 95
Pathophysiology and treatment of patients with beta-thalassemia – an update
Fibach, E., & Rachmilewitz, E. A. (2017) · F1000Research · doi:10.12688/f1000research.12688.1 · Cited by 108
Ineffective Erythropoiesis: Anemia and Iron Overload
Gupta, R., Musallam, K. M., Taher, A. T., & Rivella, S. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.11.009 · Cited by 90
Interacting signals in the control of hepcidin expression
Darshan, D., & Anderson, G. J. (2009) · BioMetals · doi:10.1007/s10534-008-9187-y · Cited by 113
Smad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice
Wang, C.-Y., Core, A. B., Canali, S., Zumbrennen-Bullough, K. B., Ozer, S., Umans, L., Zwijsen, A., & Babitt, J. L. (2017) · Blood · doi:10.1182/blood-2016-12-759423 · Cited by 86
Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic Review
Nielsen, O. H., Ainsworth, M., Coskun, M., & Weiss, G. (2015) · Medicine · doi:10.1097/md.0000000000000963 · Cited by 88
Volke, M., Gale, D. P., Maegdefrau, U., Schley, G., Klanke, B., Bosserhoff, A.-K., Maxwell, P. H., Eckardt, K.-U., & Warnecke, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007875 · Cited by 93
“Liver-specific SMAD4 (the common downstream mediator for all TGF-b superfamily ligands) knock-out mice exhibit marked iron accumulation and fail to increase hepcidin expression in response to TGF-b1, BMP-4, IL-6 or iron overload, suggesting a common role for SMAD4 in the manifold pathways of hepcidin regulation [14].”
BackgroundRegulation of hepcidin expression at high altitude
Talbot, N. P., Lakhal, S., Smith, T. G., Privat, C., Nickol, A. H., Rivera-Ch, M., León-Velarde, F., Dorrington, K. L., Mole, D. R., & Robbins, P. A. (2012) · Blood · doi:10.1182/blood-2011-03-341776 · Cited by 93
Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management
Sleiman, J., Tarhini, A., Bou‐Fakhredin, R., Saliba, A. N., Cappellini, M. D., & Taher, A. T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010182 · Cited by 96
Nemeth, E. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05585.x · Cited by 105
Hereditary Sideroblastic Anemias: Pathophysiology, Diagnosis, and Treatment
Camaschella, C. (2009) · Seminars in Hematology · doi:10.1053/j.seminhematol.2009.07.001 · Cited by 98
Xiang, J., Wu, D.-C., Chen, Y., & Paulson, R. F. (2015) · Blood · doi:10.1182/blood-2014-07-591453 · Cited by 98
GDF15 knockdown promotes erastin-induced ferroptosis by decreasing SLC7A11 expression
Chen, L., Qiao, L., Bian, Y., & Sun, X. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.03.079 · Cited by 93
Robach, P., Recalcati, S., Girelli, D., Gelfi, C., Aachmann-Andersen, N. J., Thomsen, J. J., Norgaard, A. M., Alberghini, A., Campostrini, N., Castagna, A., et al. (2009) · Blood · doi:10.1182/blood-2008-09-178095 · Cited by 87
Regulators of hepcidin expression
Roth, M., Meynard, D., & Coppin, H. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.01.005 · Cited by 97
Bone morphogenic proteins in iron homeostasis
Xiao, X., Alfaro-Magallanes, V. M., & Babitt, J. L. (2020) · Bone · doi:10.1016/j.bone.2020.115495 · Cited by 94
“Other proposed erythroid regulators of hepcidin include platelet-derived growth factor-BB and growth and differentiation factor 15, but their functional roles are less certain [1, 107, 108].”
BackgroundWeber, S., Parmon, A., Kurrle, N., Schnütgen, F., & Serve, H. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.627662 · Cited by 94
de Mast, Q., Nadjm, B., Reyburn, H., Kemna, E. H. J. M., Amos, B., Laarakkers, C. M. M., Silalye, S., Verhoef, H., Sauerwein, R. W., Swinkels, D. W., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/595790 · Cited by 89
“So far, hypoxia inducible factor–1 [12], soluble hemojuvelin [43], and growth differentiation factor 15 [44] have been reported to be potentially involved in pathways connecting bone marrow activity to hepcidin production.”
Raghavachari, N., Barb, J., Yang, Y., Liu, P., Woodhouse, K., Levy, D., O‘Donnell, C. J., Munson, P. J., & Kato, G. J. (2012) · BMC Medical Genomics · doi:10.1186/1755-8794-5-28 · Cited by 90
“Interestingly, GDF15 expression was upregulated, which also has been observed in thalassemia intermedia, and associated with repression of hepcidin, an important mediator of the inflammatory response on erythropoiesis [35].”
BackgroundTargeting the Hepcidin-Ferroportin Axis in the Diagnosis and Treatment of Anemias
Nemeth, E. (2010) · Advances in Hematology · doi:10.1155/2010/750643 · Cited by 86
Hepcidin and iron disorders: new biology and clinical approaches
Arezes, J., & Nemeth, E. (2015) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12358 · Cited by 88
“factors, possibly erythroferrone [8] and GDF15 [17], by developing erythroblasts.”
BackgroundAgarwal, A. K., & Yee, J. (2019) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2019.04.005 · Cited by 99
Iron Overload in Sickle Cell Disease
Raghupathy, R., Manwani, D. G., & Little, J. A. (2010) · Advances in Hematology · doi:10.1155/2010/272940 · Cited by 95
“Serum from TM patients suppresses hepcidin expression in vitro, unless GDF-15 is blocked [60].”
BackgroundThe role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia
Fibach, E., & Rachmilewitz, E. A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05577.x · Cited by 87
Pardanani, A., Finke, C., Abdelrahman, R. A., Lasho, T. L., & Tefferi, A. (2013) · American Journal of Hematology · doi:10.1002/ajh.23406 · Cited by 82
“…between hemoglobin and hepcidin levels is reminiscent of the suppressive effect of increased erythropoietic drive on hepcidin levels that has been described in thalassemic patients, particularly those who are transfusion na € ıve [18], possibly acting through growth differentiation factor 15 [19].”
A variant erythroferrone disrupts iron homeostasis in SF3B1 -mutated myelodysplastic syndrome
Bondu, S., Alary, A.-S., Lefèvre, C., Houy, A., Jung, G., Lefebvre, T., Rombaut, D., Boussaid, I., Bousta, A., Guillonneau, F., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav5467 · Cited by 85
Self-citationRegulation of Hepcidin by Erythropoiesis: The Story So Far
Pasricha, S.-R., McHugh, K., & Drakesmith, H. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050731 · Cited by 80
“(89) reported that treating liver cells with high doses of GDF-15 could suppress hepcidin expression in vitro.”
BackgroundRecycling Iron in Normal and Pathological States
Beaumont, C., & Delaby, C. (2009) · Seminars in Hematology · doi:10.1053/j.seminhematol.2009.06.004 · Cited by 104
van der Putten, K., Jie, K. E., van den Broek, D., Kraaijenhagen, R. J., Laarakkers, C., Swinkels, D. W., Braam, B., & Gaillard, C. A. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq099 · Cited by 82
Pathophysiology and classification of iron overload diseases; update 2018
Brissot, P., Troadec, M., Loréal, O., & Brissot, É. (2018) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2018.08.006 · Cited by 90
Metadata
- Authors
- Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., Eling, T. E., Childs, R., Ganz, T., Leitman, S. F., Fucharoen, S., & Miller, J. L.
- Affiliations
- National Institutes of Health (US)
- Walter Reed National Military Medical Center (US)
- Children's National (US)
- University of California, Los Angeles (US)
- Mahidol University (TH)
- Corresponding author
- Miller, Jeffery L
- Venue
- Nature Medicine
- Published
- 2007-08-26
- Volume
- 13
- Issue
- 9
- Pages
- 1096-1101
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2107423980
- Cited by
- 854
- References
- 32
- Citations by year
- 2026: 15 · 2025: 19 · 2024: 15 · 2023: 26 · 2022: 27 · 2021: 52 · 2020: 40 · 2019: 37 · 2018: 44 · 2017: 45 · 2016: 47 · 2015: 55 · 2014: 55 · 2013: 54 · 2012: 53
- FWCI
- 40.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › GDF15 and Related Biomarkers
- Keywords
- GDF15, growth differentiation factor 15, beta-thalassemia, hepcidin, iron overload, erythropoiesis, erythroblasts, soluble transferrin receptor, ferritin, erythropoietin, hepatocytes, iron regulation
- MeSH terms
- Gene Expression Regulation, Humans, Reference Values, RNA, Messenger, Thalassemia, Transcription, Genetic, Polymerase Chain Reaction, Cytokines, Gene Expression Profiling, Antimicrobial Cationic Peptides, Growth Differentiation Factor 15, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.